Clinical trial
Evaluation the Effect of Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Type 2 Diabetic Iraqi Patients
NCT07172269 is registered in ClinicalTrials.gov with Mais Qais Hbeeb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation the Effect of Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Type 2 Diabetic Iraqi Patients
- Lead sponsor
- Mais Qais Hbeeb
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2024
- Completion date
- May 26, 2025
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabete mellitus, dyslipidemia in patients with diabetes mellitus, insulin resistance, obesity type 2 diabetes mellitus, type 2 diabetes